Budgeting for Opioid Addiction Treatment Act (HR 2038, 115th Congress)

Policy Details

Policy Details

Originating Entity
Last Action
Referred to Subcommittee
Date of Last Action
Apr 7 2017
Congressional Session
115th Congress
Date Introduced
Apr 6 2017
Publication Date
Jan 10 2019

SciPol Summary

HR 2038S 523, the Budgeting for Opioid Treatment Act, would establish a $0.01 / milligram "stewardship fee" for active opioid products sold by the manufacturer, producer, or importer of those products. This new revenue would be directed to the States to fund substance abuse initiatives, such as establishing new treatment facilities, hiring new mental health providers, or expanding access to long-term, residential treatment programs.


View the full brief and ways you can engage

Full Brief